GSI 7985 (Harvoni ledipasvir 90 mg / sofosbuvir 400 mg)
Generic Name: ledipasvir/sofosbuvir
Pill with imprint GSI 7985 is Orange, Four-sided and has been identified as Harvoni ledipasvir 90 mg / sofosbuvir 400 mg. It is supplied by Gilead Sciences, Inc.
Harvoni is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Harvoni ledipasvir 90 mg / sofosbuvir 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI 7985
Harvoni
- Generic Name
- ledipasvir/sofosbuvir
- Imprint
- GSI 7985
- Strength
- ledipasvir 90 mg / sofosbuvir 400 mg
- Color
- Orange
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 61958-1801
- Inactive Ingredients
-
alcohol,
copovidone,
lactose monohydrate,
microcrystalline cellulose,
silicon dioxide,
croscarmellose sodium,
magnesium stearate,
water,
titanium dioxide,
polyethylene glycol 3350,
magnesium silicate,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
More about Harvoni (ledipasvir / sofosbuvir)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (396)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: antiviral combinations
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.